T.TH
|
goal: 1 study for approval. In US and EUROPE 3 years exclusivity in US 10...
|
T.TH
|
From the conference call. Tanguay's words. New phase 3 trial for HIV...
|
T.TH
|
PALINC WROTE: "Drawing conclusions on TH stock movement is hazardous to...
|
T.TH
|
It took a long year, But it seems that the last week of trading is showing...
|
T.TH
|
European Medicine Agency Grants Theratechnologies an Additional Month to...
|
T.TH
|
Muslix, yes I know that the last year logic is : good news DOWN, bad news...
|
T.TH
|
Paul the robot ! Do you read this board ? FTV.
|
T.TH
|
In addition to reviewing highlights from last year, both Ms. Svoronos and Mr....
|
T.TH
|
This board is amazing ! NASH: coming soon. FTV.
|
T.TH
|
What I am reading here is some very hard "critique" for directors...
|
T.TH
|
Theratechnologies’ CFO to Attend RBC Capital Markets Healthcare Conference in...
|
T.TH
|
Under "Whats new" on the website. Published on may 8. And...
|
T.TH
|
Her is my post from april 16. And, you have the possibility to verify their...
|
T.TH
|
Seller of more than 30 000 shares rapidly this morning is CANACCORD.............
|
T.TH
|
You are right MUSLIX.......something is going on since a couple of weeks with...
|
T.TH
|
Hopefully: month of may equals Europe approval for Trogarzo and news...
|
T.TH
|
This is from the press release in april about the EGRIFTA's grinspoon...
|
T.TH
|
Hey Muslix, What is your call for the next few weeks ? Do you see a big...
|
T.TH
|
Some here, in the last year, posted that TH/THERF and TAIMED share price were...
|
T.TH
|
Even old shareholders and posters are back to give their opinion here as we...
|